Sign In to Follow Application
View All Documents & Correspondence

Compositions And Methods For Inhibiting Mitochondria Amidoxime Reducing Component 1 (Marc1) Expression

Abstract: Oligonucleotides are provided herein that inhibit MARC1 expression. Also provided are compositions including the same and uses thereof, particularly uses relating to treating diseases, disorders and/or conditions associated with MARC1 expression.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
18 December 2023
Publication Number
02/2024
Publication Type
INA
Invention Field
BIOTECHNOLOGY
Status
Email
Parent Application

Applicants

NOVO NORDISK A/S
Novo Allé 2880 Bagsværd
DICERNA PHARMACEUTICALS, INC.
75 Hayden Avenue Lexington, 02421

Inventors

1. DUDEK, Henryk
Dicerna Pharmaceuticals, Inc. 75 Hayden Avenue Lexington, MA02421
2. HAN, Wen
Dicerna Pharmaceuticals, Inc. 75 Hayden Avenue Lexington, MA02421
3. PURSELL, Natalie, Wayne
Dicerna Pharmaceuticals, Inc. 75 Hayden Avenue Lexington, MA02421
4. LAI, Chengjung
Dicerna Pharmaceuticals, Inc. 75 Hayden Avenue Lexington, MA02421
5. HAYNES, William, Geoffrey
Novo Nordisk Ltd. Old Road Campus Roosevelt Drive Oxford OX3 7FZ
6. DING, Zhihao
Beijing Novo Nordisk Pharmaceuticals Sci & Tech Co. Ltd Building #2/#4, Bio-tech R&D Center, No.20 Life Science Park Road Beijing, Beijing 102206

Specification

Documents

Application Documents

# Name Date
1 202347086505-STATEMENT OF UNDERTAKING (FORM 3) [18-12-2023(online)].pdf 2023-12-18
2 202347086505-Sequence Listing in txt [18-12-2023(online)].txt 2023-12-18
3 202347086505-Sequence Listing in PDF [18-12-2023(online)].pdf 2023-12-18
4 202347086505-PRIORITY DOCUMENTS [18-12-2023(online)].pdf 2023-12-18
5 202347086505-POWER OF AUTHORITY [18-12-2023(online)].pdf 2023-12-18
6 202347086505-FORM 1 [18-12-2023(online)].pdf 2023-12-18
7 202347086505-DRAWINGS [18-12-2023(online)].pdf 2023-12-18
8 202347086505-DECLARATION OF INVENTORSHIP (FORM 5) [18-12-2023(online)].pdf 2023-12-18
9 202347086505-COMPLETE SPECIFICATION [18-12-2023(online)].pdf 2023-12-18
10 202347086505-FORM 18 [21-12-2023(online)].pdf 2023-12-21
11 202347086505-Proof of Right [04-06-2024(online)].pdf 2024-06-04